Speaker

Dr. Lynch received her undergraduate and graduate degrees in Microbiology from University College Dublin, Ireland, before completing her postdoctoral training as a Dean’s Fellow in the Department of Microbiology and Immunology at Stanford University. Her research focuses on how the human microbiome promotes immune dysfunction and chronic inflammatory disease and in translating findings from these studies into a new range of prognostics and interventional treatments. She has served on a National Academy of Science and Engineering committee and as an American Society of Microbiology, Distinguished Lecturer. She has received several awards including the Rebecca Buckley lectureship and the David S. Perlman lectureship from the AAAAI and was named as one of Foreign Policy Magazine’s "Global Thinkers”. She has published more than 200 papers including key articles in Nature Medicine, New England Journal of Medicine and Cell. In 206, she co-founded Siolta Therapeutics Inc., a biotech company whose lead microbial live biotherapeutic for the prevention of childhood atopy and asthma is currently in a phase 2 human clinical trial.

« Go Back